Vol 18, No 2 (2021)
Research paper
Published online: 2021-03-02
Get Citation

Results of the nationwide survey „PolDrugs 2021”: Polish users of psychoactive substances, who are they?

Gniewko Więckiewicz, Robert Pudlo
DOI: 10.5603/PSYCH.a2021.0006
·
Psychiatria 2021;18(2):119-128.

paid access

Vol 18, No 2 (2021)
Prace oryginalne - nadesłane
Published online: 2021-03-02

Abstract

Introduction: The possibilities of the therapeutic use of illegal psychoactive substances are being researched
all over the world. Demographic and epidemiological studies are required.
The aim of the survey was to present the most important demographic data and data on the use of psychoactive
substances in Poland.

Material and methods: 2,373 responses to the original questionnaire from users from all over Poland were
collected via the Internet.

Results: People of all ages use many different psychoactive substances in many different circumstances.
The three most common agents used in Poland are marijuana, MDMA and amphetamines. 31.9% of respondents
undertook psychiatric treatment.

Conclusions: Psychiatrists rarely ask about the use of psychoactive substances. Initiation in the use of psychoactive
substances usually takes place before reaching the age of majority. Drug policy and prevention principles
need to be modified.

Abstract

Introduction: The possibilities of the therapeutic use of illegal psychoactive substances are being researched
all over the world. Demographic and epidemiological studies are required.
The aim of the survey was to present the most important demographic data and data on the use of psychoactive
substances in Poland.

Material and methods: 2,373 responses to the original questionnaire from users from all over Poland were
collected via the Internet.

Results: People of all ages use many different psychoactive substances in many different circumstances.
The three most common agents used in Poland are marijuana, MDMA and amphetamines. 31.9% of respondents
undertook psychiatric treatment.

Conclusions: Psychiatrists rarely ask about the use of psychoactive substances. Initiation in the use of psychoactive
substances usually takes place before reaching the age of majority. Drug policy and prevention principles
need to be modified.

Get Citation

Keywords

drugs, NPS, survey

About this article
Title

Results of the nationwide survey „PolDrugs 2021”: Polish users of psychoactive substances, who are they?

Journal

Psychiatria (Psychiatry)

Issue

Vol 18, No 2 (2021)

Article type

Research paper

Pages

119-128

Published online

2021-03-02

DOI

10.5603/PSYCH.a2021.0006

Bibliographic record

Psychiatria 2021;18(2):119-128.

Keywords

drugs
NPS
survey

Authors

Gniewko Więckiewicz
Robert Pudlo

References (12)
  1. Reiff CM, Richman EE, Nemeroff CB, et al. the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Psychedelics and Psychedelic-Assisted Psychotherapy. Am J Psychiatry. 2020; 177(5): 391–410.
  2. https://www.ema.europa.eu/en/documents/product-information/spravato-epar-product-information_pl. (11.12.2020).
  3. https://www.spectrumtherapeutics. (11.12.2020).
  4. Król B, Szewczak B, et al. Terapeutyczne zastosowanie wybranych substancji psychoaktywnych. Psychiatria. 2019; 16(3): 154–162.
  5. https://news.un.org/en/story/2020/12/1079132 (11.12.2020).
  6. Orsolini L, Chiappini S, Corkery JM, et al. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review. Expert Rev Neurother. 2019; 19(12): 1253–1264.
  7. Khaled SM, Hughes E, Bressington D, et al. The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol. Syst Rev. 2016; 5(1): 195.
  8. Werley MS, Kirkpatrick DJ, Oldham MJ, et al. Toxicological assessment of a prototype e-cigaret device and three flavor formulations: a 90-day inhalation study in rats. Inhal Toxicol. 2016; 28(1): 22–38.
  9. Kopa PN, Pawliczak R. IQOS - a heat-not-burn (HnB) tobacco product - chemical composition and possible impact on oxidative stress and inflammatory response. A systematic review. Toxicol Mech Methods. 2020; 30(2): 81–87.
  10. Więckiewicz G, Smardz J, et al. Wzory stosowania syntetycznych katynonów a objawy depresyjne i parafunkcyjne zachowania ustne Psychiatr. Pol. ONLINE FIRST 2020 Feb. ; 165: 1–19.
  11. Internet: https://www.cinn.gov.pl/portal?id=1675807 (12.02.2021).
  12. https://www.emcdda.europa.eu/system/files/publications/11349/poland-cdr-2019_0.pdf (12.02.2021).

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl